Patents
Literature
1 results about "Neuroectoderm" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Neuroectoderm (or neural ectoderm or neural tube epithelium) consists of cells derived from ectoderm. Formation of the neuroectoderm is first step in the development of the nervous system. The neuroectoderm receives bone morphogenetic protein-inhibiting signals from proteins such as noggin, which leads to the development of the nervous system from this tissue. Histologically, these cells are classified as pseudostratified columnar cells.
Pluripotent stem cell-derived RPE cells, formulations, pharmaceutical compositions, reagents, methods, and kits
PendingJP2026518304ASenses disorderMicrobiological testing/measurementNeuroectodermPharmacy medicine
This invention belongs to the field of regenerative medicine and relates to cell therapy, specifically providing pluripotent stem cell-derived RPE cells, formulations, pharmaceutical compositions, reagents, methods, and kits. Obtaining RPE cells by differentiation of iPSCs is achieved by adding small chemical molecules as inhibitors or activators to E6 medium and includes a neuroectoderm cell induction phase, an RPE progenitor cell induction phase, an RPE cell induction phase, and an RPE cell maturation phase. In this differentiation process, there is no need to manually remove heterogeneous cells with non-RPE-like morphology, and pure RPE cells can be obtained by subculturing.
Owner:ヘルプ リジェネラティブ メディシン テクノロジー(シェンチェン)カンパニーリミテッド